Empresas›BIAFW

BIAFW · bioAffinity Technologies, Inc.

investigacion biologica comercial · CIK 0001712762

Caja

no publicable

faltan datos o hay una emision posterior a la ultima cifra de caja conocida

Dilucion

sin datos

hacen falta dos recuentos de acciones

Ultimo documento

7 ago 2026

Informe trimestral

Documentos presentados ante la SEC

2026

1. 7 ago 202610-QInforme trimestralEDGAR

   Duda sustancial sobre la continuidad de la empresa…), the Company has evaluated whether there are conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date the condensed consolidated financial state…

   Contrasplit de acciones…are not eligible for the standard 180-calendar day compliance period because we effected a 1-for-30 reverse stock split on September 19, 2025, which occurred within the prior one-year period. We have…

2. 7 ago 20268-KHecho relevanteEDGAR
3. 31 jul 20268-KHecho relevanteEDGAR
4. 27 jul 20268-KHecho relevanteEDGAR
5. 22 jul 20268-KHecho relevanteEDGAR
6. 7 jul 20268-KHecho relevanteEDGAR
7. 30 jun 20268-KHecho relevanteEDGAR
8. 12 jun 2026CORRESPCorrespondencia con la SECEDGAR
9. 11 may 2026CORRESPCorrespondencia con la SECEDGAR
10. 7 may 2026UPLOADCarta de comentarios de la SECEDGAR
11. 7 may 2026UPLOADCarta de comentarios de la SECEDGAR